This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Johnson & Johnson (JNJ)

NYSE: Health Care

Insider Trading
Historical Data Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago 4 Mo. Ago 5 Mo. Ago 6 Mo. Ago
Net Insider Transaction 2,500 5,000 2,500 43,933 41,433 114,560 116,960
Shares Bought 2,500 5,000 2,500 231,183 343,990 481,621 322,458
Shares Sold 0 0 0 187,250 302,557 367,061 205,498
Institutional Trading
Historical Data Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago 4 Mo. Ago 5 Mo. Ago 6 Mo. Ago
Total Shares Held 1.84B 1.90B 1.92B 1.93B 1.93B 1.93B 1.95B
Shares Bought 106.02M 93.60M 95.00M 97.50M 97.50M 97.50M 116.13M
Shares Sold 115.19M 115.84M 83.01M 84.31M 84.31M 84.31M 99.40M
JNJ News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

JNJ Johnson & Johnson

Chart of JNJ

Analysts Ratings for JNJ

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 6 5 6
Moderate Buy 2 2 2 2
Hold 7 7 7 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

JNJ Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs